Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC. -- Ignore unavailable to you. Want to Upgrade?

To: Epics who wrote (123)	4/29/1998 11:01:00 PM
From: Lighthouse	Respond to of 211

I would agree that breakeven operating results are not in the cards near term. Unfortunately this stock (next six months) is going to be largely driven by the legal front. Right now: A CA judge is currently hearing the arbitration case with GDT and we will know an answer within the next two months. We got a small pop from the summary judgement decision and if we win the arbitration case we may get another. Alot like building blocks. The big enchillada IMHO is the trial in September (if this date holds- since all the other dates have not). GDT has 20,000 balloon sales per quarter on the line. An instant revenue stream? If GSII wins with the Beonutii patent then things will get very interesting. I bet Steve Bonelli and the guys at GSII will go for damages as well as royalties if they win. Right Steve? Regards,